Severe immune thrombocytopenia in a critically ill COVID-19 patient
Ziga Martincic, Barbara Skopec, Karla Rener, Matej Mavrič, Tomaž Vovko, Matjaž Jereb, Milica Lukić
Abstract
The novel coronavirus SARS-CoV-2 can cause a severe and even fatal respiratory illness named COVID-19. Apart from respiratory failure, COVID-19 may be associated with various autoimmune complications. We present a case of a critically ill patient with COVID-19 who developed severe immune thrombocytopenia that was successfully treated with a concomitant use of corticosteroids and intravenous immunoglobulins.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Critically illMedicineConcomitantRespiratory failureSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Immune systemCritical illness2019-20 coronavirus outbreakRespiratory systemAntibodyCoronavirusIntensive care medicineImmunologyVirologyInternal medicineInfectious disease (medical specialty)DiseaseOutbreakPlatelet Disorders and TreatmentsBlood groups and transfusionBlood properties and coagulation